Histologically, parosteal osteosarcoma resembles other benign fibroosseous or fibrous diseases of soft tissue and bone.
As in most bone pathology, the importance of clinical, radiologic, and pathologic correlation cannot be overemphasized in diagnosing parosteal osteosarcoma. A simple diagnostic algorithm is proposed for the histologic discrimination of osteogenic lesions arising from the bone cortical surface (Figure 4).
Dedifferentiation of parosteal osteosarcoma has been reported in 16% to 43% of cases, either concurrently or metachronously in recurrent tumor.
Early studies (2,10,23,27) demonstrated an association between histologic grade and prognosis in parosteal osteosarcoma. A 4-tier grading system is most commonly used, but the criteria are arbitrary.
Parosteal osteosarcoma is a slow-growing malignant bone tumor most commonly occurring in young women.
MRI findings in parosteal osteosarcoma: correlation with histopathology.
Parosteal osteosarcoma: value of MR imaging and CT in the prediction of histologic grade.
Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: a combined cytogenetic and comparative genomic hybridization study.
Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene.
12q Amplification defines a subtype of extraskeletal osteosarcoma with good prognosis that is the soft tissue homologue of parosteal osteosarcoma. Cancer Genet.
Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute.
Conventional and dedifferentiated parosteal osteosarcoma: diagnosis, treatment, and outcome.